CXCR2 inhibition enables NASH-HCC immunotherapy (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2022.02.24.481779

Publication URI: http://dx.doi.org/10.1101/2022.02.24.481779

Type: Preprint